IP Library › Assignment 040520/0537
Patent Assignment
Reel/Frame 040520/0537

Change of Name

Recorded: 2016-10-31 Pages: 4
Assignor
MODERNA THERAPEUTICS, INC.
Executed: 2016-08-08
Assignee
MODERNATX, INC.
200 TECHNOLOGY SQUARE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (2)
Alternative Nucleic Acid Molecules Containing Reduced Uracil Content and Uses Thereof
Patent: 9,751,925 →
Application: 14/960,031 →
Publication: US 2016/0237134
Alternative Nucleic Acid Molecules Containing Reduced Uracil Content and Uses Thereof
Application: 62/077,871 →
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 19, 2014
From: VAN WICHEREN REYNDERS, JOHN, III; HOGE, STEPHEN G.; STANTON, MATTHEW
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 034558/0854 →
Assignment of Assignor's Interest Mar 18, 2016
From: HOGE, STEPHEN G.; ISSA, WILLIAM JOSEPH; MIRACCO, ED; NELSON, JENNIFER
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 038033/0457 →
Assignment of Assignor's Interest Nov 29, 2017
From: REYNDERS, JOHN
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 044248/0794 →
Security Interest Nov 19, 2025
From: MODERNATX, INC.
To: ARES CAPITAL CORPORATION, AS AGENT
Reel/Frame 073634/0354 →